Insulin pens and vials According to the complaint, PillPack would dispense and bill for a full carton of insulin pens and falsely underreport the days of supply. (Photo: Daniel Beckemeier/

The United States has settled a health care fraud lawsuit against online retail pharmacy PillPack LLC, a wholly owned subsidiary of Inc. The move resolves allegations that PillPack improperly billed government health care programs — including Medicare and Medicaid — for more insulin pens than patients needed based on their prescriptions and falsely under-reported the “days of supply” of insulin dispensed.

Damian Williams, the United States Attorney for the Southern District of New York, and Scott J. Lampert, Special Agent-in-Charge of the U.S. Department of Health and Human Services Office of the Inspector General New York Regional Office, made the joint announcement May 2.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.